Original news and analysis on international IP policy
Ukrainian lawmakers are poised to approve sweeping patent reform legislation, driven in large part by a push by patients’ groups for better access to affordable medicines and healthcare.
The annual Special 301 report of the Office of the United States Trade Representative (USTR) issued today sparked a quick outcry among health advocates over its seemingly more restrictive approach they say bullies other countries into unfairly promoting US pharmaceutical industry rights to an extent that would raise drug prices and limit accessibility.
The European Commission today issued an outline of a European approach on artificial intelligence to "boost investment and set ethical guidelines." The aim is to have a coordinated plan with member states by year's end.
Weevil-infested flour, deadly methanol added to alcohol, borax to make products seem fresher, pesticide-laced shrimp, fake medicines. Global police organisation Interpol today detailed a multi-agency operation that dismantled nearly 50 criminal networks worldwide that provided fake and substandard food and drink that put people in danger and killed dozens.
A wide-ranging list of international nongovernmental organisations today issued a letter to European Trade Commissioner Cecilia Malmström opposing a proposal to establish a "watch list" of countries deemed failing to protect European intellectual property. The groups raised concern that the list would violate World Trade Organization rules on intellectual property, have a chilling effect on developing countries' public health initiatives, and lead to expanded and untenable levels of IP enforcement.
Research collaborations between institutions in the North and institutions in the South often show a scientific and power imbalance. In the context of growing concerns about this issue, initiatives are being developed to increase fairness in research partnerships. In particular, the Research Fairness Initiative, providing a reporting system for institutions is gaining traction, according to speakers at the Geneva Health Forum this week.
Achieving a high percentage of universal health coverage often does not translate into a high quality of health systems, according to speakers at the opening of the Geneva Health Forum. While in developed countries people are demanding better quality, the expectations of people living in low and middle-income countries need to be raised, they said. Another panel looked at the use of big data and mathematical modelling as ways to improve health systems, including Facebook monitoring.
“Access to genetic resources” and “the fair and equitable sharing of benefits arising from their utilization” have beleaguered all thirteen Conferences of the Parties to the 1993 United Nations Convention on Biological Diversity (CBD), a group of academics writes. The expression in quotes constitutes the third objective of the Convention and is intertwined with the first two, conservation and sustainable use. It goes by the acronym “ABS”. Despite 25 years of efforts and an annual bio-economy of nearly one trillion dollars, few contracts have ever been concluded. And of those very few, the monetary benefits are so low that contracting parties are loathe to disclose them. The “Brazilian ABS Law” of 2015, which came into effect on 6 November 2017, even allows royalties on net sales to be as low as one tenth of one percent. In the words of one distinguished legal scholar, Users are paying “peanuts for biodiversity.”
A decision to keep third party listeners out of communications on the internet taken by the Internet Engineering Task Force (IETF) at their recent meeting in London elicited an alarmist message from the US financial industry. The premier internet standardisation body would provide “privacy for crooks,” and practically prohibit “bank security guards from patrolling and checking particular rooms” online, BITS, the technology division of the Financial Services Roundtable, argued in a press release last week. Has standardisation gone rogue?
Actions by governments in recent days show funding for global health continues to be a priority for some countries. Geneva-based institutions and their programs around the world are among the beneficiaries.
The Universities Allied for Essential Medicines (UAEM) this week launched a campaign to ask the University of California to drop its pursuit of a patent on the prostrate cancer drug Xtandi in India in order to make it affordable for patients. Xtandi sells at "exorbitant" rates in the United States, they said, a seeming violation of the licensing guidelines of the publicly funded University of California system which guarantees an "appropriate" return on taxpayer investments.
NEW YORK -- A major event on innovation and access to health technologies took place at the United Nations in New York last week, in which UN member states were briefed on ideas and efforts to promote these issues at the forefront of global health policy.